BOYER ANDREW S
SEC CIK 1239546 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AMRX | Amneal Pharmaceuticals, Inc. | EVP | 193.6K | — | $4.65M | 36 | 2021-06-30 | 2026-09-01 |
Most active insiders at AMRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Shah Nikita | EVP | — | $4.14M |
| 2 | Daly Jason B. | EVP, CLO | — | $3.77M |
| 3 | Kiely John | Dir | — | $882.0K |
| 4 | Nark Ted C | Dir | — | $586.0K |
| 5 | Autor Deborah M. | Dir | — | $450.6K |
| 6 | George Jeffrey P. | Dir | — | — |
| 7 | Patel Tushar Bhikhubhai | 10% | — | — |
| 8 | Patel Chirag K. | Pres, Co-CEO, Dir | — | — |
| 9 | Patel Gautam | Dir | — | — |
| 10 | Patel Chintu | Co-CEO, Dir | — | — |
| 13 | BOYER ANDREW S | EVP | — | — |
Transactions 36
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-02 17:03 | 2026-09-01 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | G - Gift | $0.00 | -80.0K | 193.6K | -29% | $0 | |
| 2026-08-25 16:41 | 2026-08-21 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | G - Gift | $0.00 | -152.4K | 273.6K | -36% | $0 | |
| DM | 2026-03-05 | 2026-03-03+ | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | F - Tax | $13.31 | -275.3K | 171.7K | -62% | -$3.66M |
| DM | 2026-03-05 | 2026-03-03+ | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | M - OptEx | — | +549.0K | 191.7K | New | — |
| D | 2025-08-22 | 2025-08-20 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | M - OptEx | $2.75 | +175.0K | 431.7K | +68% | +$481.2K |
| D | 2025-08-22 | 2025-08-20 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | S - Sale+OE | $9.38 | -279.2K | 152.4K | -65% | -$2.62M |
| 2025-08-13 | 2025-08-12 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | S - Sale | $9.05 | -33.4K | 256.7K | -12% | -$302.6K | |
| 2025-03-07 | 2025-03-05 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | S - Sale | $8.89 | -125.0K | 290.1K | -30% | -$1.11M | |
| DM | 2025-03-05 | 2025-03-03+ | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | M - OptEx | — | +284.1K | 434.6K | +189% | — |
| DM | 2025-03-05 | 2025-03-03+ | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | F - Tax | $8.77 | -145.3K | 319.8K | -31% | -$1.27M |
| D | 2025-03-04 | 2025-03-01 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | F - Tax | $8.67 | -11.7K | 276.3K | -4% | -$101.8K |
| D | 2025-03-04 | 2025-03-01 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | M - OptEx | — | +31.4K | 288.0K | +12% | — |
| M | 2024-08-16 | 2024-08-14+ | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | S - Sale | $7.84 | -62.7K | 296.9K | -17% | -$491.4K |
| DM | 2024-03-05 | 2024-03-01+ | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | M - OptEx | — | +120.3K | 344.3K | +54% | — |
| DM | 2024-03-05 | 2024-03-01+ | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | F - Tax | $5.47 | -60.8K | 294.6K | -17% | -$332.5K |
| D | 2024-02-29 | 2024-02-27 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | F - Tax | $5.71 | -16.6K | 259.8K | -6% | -$94.5K |
| D | 2024-02-29 | 2024-02-27 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | M - OptEx | — | +31.7K | 276.4K | +13% | — |
| 2023-08-15 | 2023-08-11 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | S - Sale | $4.13 | -29.3K | 244.7K | -11% | -$121.0K | |
| D | 2023-07-05 | 2023-06-30 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | M - OptEx | — | +23.1K | 285.6K | +9% | — |
| D | 2023-07-05 | 2023-06-30 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | F - Tax | $3.10 | -11.6K | 274.0K | -4% | -$35.9K |
| D | 2023-03-07 | 2023-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | M - OptEx | — | +39.3K | 282.2K | +16% | — |
| D | 2023-03-07 | 2023-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | F - Tax | $1.92 | -19.7K | 262.5K | -7% | -$37.8K |
| DM | 2023-03-03 | 2023-03-01 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | M - OptEx | — | +43.7K | 259.1K | +20% | — |
| DM | 2023-03-03 | 2023-03-01 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | F - Tax | $2.09 | -23.0K | 227.7K | -9% | -$48.0K |
| D | 2023-03-01 | 2023-02-27 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | M - OptEx | — | +31.7K | 239.8K | +15% | — |
| D | 2023-03-01 | 2023-02-27 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | F - Tax | $2.16 | -17.6K | 222.2K | -7% | -$37.9K |
| D | 2022-07-05 | 2022-06-30 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | F - Tax | $3.18 | -11.6K | 208.1K | -5% | -$36.8K |
| D | 2022-07-05 | 2022-06-30 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | M - OptEx | — | +23.1K | 219.7K | +12% | — |
| D | 2022-05-10 | 2022-05-07 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | F - Tax | $3.40 | -8,353 | 196.6K | -4% | -$28.4K |
| D | 2022-05-10 | 2022-05-07 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | M - OptEx | — | +16.7K | 204.9K | +9% | — |
| DM | 2022-03-03 | 2022-03-01 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | M - OptEx | — | +43.7K | 204.0K | +27% | — |
| DM | 2022-03-03 | 2022-03-01 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | F - Tax | $4.45 | -21.9K | 172.6K | -11% | -$97.6K |
| D | 2022-03-01 | 2022-02-27 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | F - Tax | $4.59 | -16.4K | 166.5K | -9% | -$75.4K |
| D | 2022-03-01 | 2022-02-27 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | M - OptEx | — | +31.7K | 182.9K | +21% | — |
| D | 2021-07-01 | 2021-06-30 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | M - OptEx | — | +23.1K | 162.8K | +17% | — |
| D | 2021-07-01 | 2021-06-30 | AMRX | Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | EVP | F - Tax | $5.12 | -11.6K | 151.3K | -7% | -$59.3K |
Purchase Sale Sale after option exercise All abbreviations